Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure

• Nicolas Clementy ,

  Roles Writing – original draft, Writing – review & editing

  * E-mail: nclementy@yahoo.fr

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  http://orcid.org/0000-0002-7415-0787

  ⨯
• Bruno Garcia,

  Roles Data curation, Investigation

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Clémentine André,

  Roles Validation

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Arnaud Bisson,

  Roles Software, Validation

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Nazih Benhenda,

  Roles Supervision, Validation

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Bertrand Pierre,

  Roles Investigation

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Anne Bernard,

  Roles Investigation, Validation

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Laurent Fauchier,

  Roles Writing – review & editing

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Eric Piver,

  Roles Investigation, Resources, Writing – review & editing

  Affiliation Biochemistry Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯
• Dominique Babuty

  Roles Funding acquisition, Supervision, Writing – review & editing

  Affiliation Cardiology Department, Trousseau Hospital, University of Tours, Tours, France

  ⨯